[Genetic factors influencing efficacy of clopidogrel treatment]

Kardiol Pol. 2012;70(11):1177-81.
[Article in Polish]
No abstract available

Publication types

  • Review

MeSH terms

  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Aryldialkylphosphatase / genetics*
  • Blood Platelets / metabolism
  • Clopidogrel
  • Drug Resistance / genetics*
  • Humans
  • Liver / enzymology
  • Myocardial Ischemia / drug therapy*
  • Myocardial Ischemia / enzymology
  • Myocardial Ischemia / genetics*
  • Platelet Activation / genetics*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Polymorphism, Genetic
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Aryl Hydrocarbon Hydroxylases
  • Aryldialkylphosphatase
  • Ticlopidine